PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 188 filers reported holding PACIRA PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $5,808 | +102.8% | 203 | +107.1% | 0.00% | – |
| Q1 2024 | $2,864 | -99.3% | 98 | -99.0% | 0.00% | -100.0% |
| Q3 2019 | $391,000 | -16.1% | 10,259 | -4.2% | 0.00% | -33.3% |
| Q2 2019 | $466,000 | -69.9% | 10,709 | -73.7% | 0.00% | -62.5% |
| Q1 2019 | $1,549,000 | +11.1% | 40,688 | +25.6% | 0.01% | 0.0% |
| Q4 2018 | $1,394,000 | -24.5% | 32,402 | -13.8% | 0.01% | -11.1% |
| Q3 2018 | $1,847,000 | +26.8% | 37,583 | -17.3% | 0.01% | +28.6% |
| Q2 2018 | $1,457,000 | -8.7% | 45,453 | -11.3% | 0.01% | -12.5% |
| Q1 2018 | $1,596,000 | -25.8% | 51,247 | +8.8% | 0.01% | -27.3% |
| Q4 2017 | $2,150,000 | +42.5% | 47,088 | +17.2% | 0.01% | +37.5% |
| Q3 2017 | $1,509,000 | -57.7% | 40,174 | -46.2% | 0.01% | -20.0% |
| Q2 2017 | $3,564,000 | – | 74,732 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Doma Perpetual Capital Management LLC | 1,000,761 | $28,631,772 | 13.28% |
| GAGNON SECURITIES LLC | 596,591 | $17,068,469 | 3.84% |
| Sio Capital Management, LLC | 455,500 | $13,031,855 | 3.53% |
| Gagnon Advisors, LLC | 133,390 | $3,816,288 | 2.91% |
| AlphaCentric Advisors LLC | 117,500 | $3,361,675 | 2.48% |
| ARDSLEY ADVISORY PARTNERS LP | 580,000 | $16,593,800 | 2.44% |
| RICE HALL JAMES & ASSOCIATES, LLC | 998,625 | $28,570,661 | 1.71% |
| Lisanti Capital Growth, LLC | 138,830 | $3,971,926 | 0.96% |
| Bridge City Capital, LLC | 84,856 | $2,427,730 | 0.82% |
| Rock Springs Capital Management LP | 785,000 | $22,458,850 | 0.68% |